It gives the study a physical presence.
A study-aligned letter can make the trial feel real and local, especially when it clearly explains the condition, patient profile, site location, and next step.
TrialNotice uses study-aligned direct mail, recipient-level QR tracking, email, LinkedIn, and SDR follow-up to help clinical trial sites reach matched local referring physicians around one active study.
Clinical trial sites often rely on digital channels first. But when you are trying to reach local physicians, a physical letter can create a different kind of moment. It can sit on the desk, be handed to a coordinator, scanned later, or used as a reference when the right patient comes to mind.
A study-aligned letter can make the trial feel real and local, especially when it clearly explains the condition, patient profile, site location, and next step.
Email alone can be missed, filtered, or ignored. Direct mail gives the outreach another path into the practice.
When email, LinkedIn, or SDR follow-up references the letter, the sequence feels connected instead of random.
A clinical trial recruitment letter to physicians has to be specific, practical, and easy to act on. The goal is not to overwhelm the doctor. The goal is to make the study understandable and referral-ready.
TrialNotice does not treat mail as a standalone campaign. The letter is part of a coordinated physician outreach sequence.
We identify local physicians and practices that are relevant to the active study, patient profile, specialty, and enrollment geography.
The letter explains the study in plain, physician-relevant language, including what kind of patient may be a fit and how the practice can take the next step.
Each letter can carry a unique QR path so engagement is tied back to the recipient and can inform follow-up priority.
Email, LinkedIn, SDR calls, and social follow-up keep the study visible after the letter arrives.
Scans, replies, and interest signals can flow into the site’s CRM, CTMS, calendar, reporting, or coordinator workflow.
Direct mail is especially useful when the study needs local physician awareness, a clear referral path, and follow-up that can be tracked across channels.
Reach specialists near the enrollment site who may already see patients that match the study profile.
Introduce a study to local primary care practices when the patient profile may appear in general practice settings.
Create physician awareness around a new study or support an active study that needs more qualified referral activity.
Follow up with physicians who previously engaged, scanned, replied, or showed interest in related study opportunities.
Direct mail can help when it is targeted to relevant physicians, written around a specific study, tracked by recipient, and supported by follow-up through email, LinkedIn, SDR calls, or other channels.
Clinical trial letters can help make local physicians aware of an active study, explain the patient profile, and give the practice a simple way to request more information or refer potential patient interest.
QR-tracked direct mail helps a clinical trial site understand which physicians engaged with the study letter and gives the team a signal for follow-up prioritization.
Usually not. The strongest approach is a coordinated sequence where direct mail is supported by email, LinkedIn, SDR follow-up, reporting, and coordinator handoff.
TrialNotice helps clinical trial sites use direct mail, QR tracking, email, LinkedIn, and SDR follow-up to build a local physician referral pipeline.
Contact us now